Concepedia

Shuji Kitahara

SK

Statistics

Publications

22

Citations

1.8K

H-Index

16

Active since

1964

Affiliations

Tokyo Women's Medical University(Current)

Massachusetts General Hospital

Harvard University

Tohoku University

Institutul Clinic Fundeni

Shuji Kitahara is an author at Tokyo Women's Medical University specializing in medicine, oncology, and molecular oncology.

Publications per year

1964–2023

22

Publications

22

CXCR4 inhibition in tumor microenvironment facilitates anti‐programmed death receptor‐1 immunotherapy in sorafenib‐treated hepatocellular carcinoma in mice

Yunching Chen, Rakesh R. Ramjiawan, Thomas Reiberger et al. · Hepatology · 2014 · 458 citations · Full text

Medicine, Oncology, Pharmacology +17

Dual Programmed Death Receptor‐1 and Vascular Endothelial Growth Factor Receptor‐2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma

Kohei Shigeta, Meenal Datta, Tai Hato et al. · Hepatology · 2019 · 410 citations · Full text

Life Sciences, Immunology, Oncology +17

IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma

Satoshi Kofuji, Akiyoshi Hirayama, Alexander Otto Eberhardt et al. · Nature Cell Biology · 2019 · 177 citations · Full text

Medicine, Molecular Biology, Oncology +10

Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma

Kohei Shigeta, Aya Matsui, Hiroto Kikuchi et al. · Journal for ImmunoTherapy of Cancer · 2020 · 151 citations · Full text

Medicine, Oncology, Pharmacology +17

Tumor-Derived Microvesicles Induce Proangiogenic Phenotype in Endothelial Cells via Endocytosis

Taisuke Kawamoto, Noritaka Ohga, Kosuke Akiyama et al. · PLoS ONE · 2012 · 100 citations · Full text

Medicine, Cell Biology, Oncology +17

1–5 of 22